Redeye: IRLAB Q1 2024 - Progress across the board
Redeye returns following IRLAB's Q1 report and the news of a development collaboration related to IRL757 in apathy. We are overall encouraged by IRLABs progress lately and raise our valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/